Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Non Operating Income (2022 - 2023)

Updated

Vitaspring Biomedical (VSBC) recorded Non Operating Income of -$4.16 million in FY2023 (year ended Jan 31, 2023).

Analysis

Vitaspring Biomedical (VSBC) Non Operating Income (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2023 -4.17 Mn
Oct 31, 2022 -637.00
Jul 31, 2022 50.00
API Access

Vitaspring Biomedical Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=VSBC&period=max&api_key=YOUR_API_KEY